Survey of SARS-CoV-2 genetic diversity in two major Brazilian cities using a fast and affordable Sanger sequencing strategy

Genetic variants of SARS-CoV-2 have been emerging and circulating in many places across the world. Rapid detection of these variants is essential since their dissemination can impact transmission rates, diagnostic procedures, disease severity, response to vaccines or patient management. Sanger seque...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Genomics (San Diego, Calif.) Calif.), 2021-11, Vol.113 (6), p.4109-4115
Hauptverfasser: Dorlass, Erick Gustavo, Lourenço, Karine Lima, Magalhães, Rubens Daniel Miserani, Sato, Hugo, Fiorini, Alex, Peixoto, Renata, Coelho, Helena Perez, Telezynski, Bruna Larotonda, Scagion, Guilherme Pereira, Ometto, Tatiana, Thomazelli, Luciano Matsumiya, Oliveira, Danielle Bruna Leal, Fernandes, Ana Paula, Durigon, Edison Luiz, Fonseca, Flavio Guimarães, Teixeira, Santuza Maria Ribeiro
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 4115
container_issue 6
container_start_page 4109
container_title Genomics (San Diego, Calif.)
container_volume 113
creator Dorlass, Erick Gustavo
Lourenço, Karine Lima
Magalhães, Rubens Daniel Miserani
Sato, Hugo
Fiorini, Alex
Peixoto, Renata
Coelho, Helena Perez
Telezynski, Bruna Larotonda
Scagion, Guilherme Pereira
Ometto, Tatiana
Thomazelli, Luciano Matsumiya
Oliveira, Danielle Bruna Leal
Fernandes, Ana Paula
Durigon, Edison Luiz
Fonseca, Flavio Guimarães
Teixeira, Santuza Maria Ribeiro
description Genetic variants of SARS-CoV-2 have been emerging and circulating in many places across the world. Rapid detection of these variants is essential since their dissemination can impact transmission rates, diagnostic procedures, disease severity, response to vaccines or patient management. Sanger sequencing has been used as the preferred approach for variant detection among circulating human immunodeficiency and measles virus genotypes. Using primers to amplify a fragment of the SARS-CoV-2 genome encoding part of the Spike protein, we showed that Sanger sequencing allowed us to rapidly detect the introduction and spread of three distinct SARS-CoV-2 variants in two major Brazilian cities. In both cities, after the predominance of variants closely related to the virus first identified in China, the emergence of the P.2 variant was quickly followed by the detection of the P1 variant, which became dominant in less than one month after it was first detected. •Detection of genetic variants of SARS-CoV-2.•Sanger Sequencing of SARS-CoV-2 variants.•Three distinct SARS-CoV-2 variants detected in two Brazilian cities.•Comparison of Sanger sequencing and Next Generation Sequencing.
doi_str_mv 10.1016/j.ygeno.2021.10.015
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8552628</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0888754321003785</els_id><sourcerecordid>2591218566</sourcerecordid><originalsourceid>FETCH-LOGICAL-c459t-492a954a6d41eb19d96f228dd02d4fe94750d4aa7cafd529f873c8f2ce084b2c3</originalsourceid><addsrcrecordid>eNp9kU1vEzEQhi0EoqHwC5CQj1w2tb32xj6A1EZAkSohEeBqOfZ4cbSxi70btPDncUip4MJppJl33vl4EHpOyZIS2l3slnMPMS0ZYbRmloSKB2hBiVSN7Hj3EC2IlLJZCd6eoSel7AghqpXsMTpr-YpK2tIF-rmZ8gFmnDzeXH7cNOv0pWG4-sIYLHbhALmEccYh4vF7wnuzSxlfZfMjDMFEbMMYoOCphNhjg70pIzbRYeN9ys5sB8AbE3vIuMC3CaI96sqYzQj9_BQ98mYo8OwunqPPb998Wl83Nx_evV9f3jSWCzU2XDGjBDed4xS2VDnVecakc4Q57kHxlSCOG7OyxjvBlJer1krPLBDJt8y25-j1yfd22u7BWYh1gUHf5rA3edbJBP1vJYavuk8HLYVgHZPV4OWdQU71ijLqfSgWhsFESFPRTCjKqBRdV6XtSWpzKiWDvx9DiT5i0zv9G5s-YjsmK7ba9eLvDe97_nCqglcnAdQ_HQJkXWyo7wQXMthRuxT-O-AXKESs-A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2591218566</pqid></control><display><type>article</type><title>Survey of SARS-CoV-2 genetic diversity in two major Brazilian cities using a fast and affordable Sanger sequencing strategy</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Dorlass, Erick Gustavo ; Lourenço, Karine Lima ; Magalhães, Rubens Daniel Miserani ; Sato, Hugo ; Fiorini, Alex ; Peixoto, Renata ; Coelho, Helena Perez ; Telezynski, Bruna Larotonda ; Scagion, Guilherme Pereira ; Ometto, Tatiana ; Thomazelli, Luciano Matsumiya ; Oliveira, Danielle Bruna Leal ; Fernandes, Ana Paula ; Durigon, Edison Luiz ; Fonseca, Flavio Guimarães ; Teixeira, Santuza Maria Ribeiro</creator><creatorcontrib>Dorlass, Erick Gustavo ; Lourenço, Karine Lima ; Magalhães, Rubens Daniel Miserani ; Sato, Hugo ; Fiorini, Alex ; Peixoto, Renata ; Coelho, Helena Perez ; Telezynski, Bruna Larotonda ; Scagion, Guilherme Pereira ; Ometto, Tatiana ; Thomazelli, Luciano Matsumiya ; Oliveira, Danielle Bruna Leal ; Fernandes, Ana Paula ; Durigon, Edison Luiz ; Fonseca, Flavio Guimarães ; Teixeira, Santuza Maria Ribeiro</creatorcontrib><description>Genetic variants of SARS-CoV-2 have been emerging and circulating in many places across the world. Rapid detection of these variants is essential since their dissemination can impact transmission rates, diagnostic procedures, disease severity, response to vaccines or patient management. Sanger sequencing has been used as the preferred approach for variant detection among circulating human immunodeficiency and measles virus genotypes. Using primers to amplify a fragment of the SARS-CoV-2 genome encoding part of the Spike protein, we showed that Sanger sequencing allowed us to rapidly detect the introduction and spread of three distinct SARS-CoV-2 variants in two major Brazilian cities. In both cities, after the predominance of variants closely related to the virus first identified in China, the emergence of the P.2 variant was quickly followed by the detection of the P1 variant, which became dominant in less than one month after it was first detected. •Detection of genetic variants of SARS-CoV-2.•Sanger Sequencing of SARS-CoV-2 variants.•Three distinct SARS-CoV-2 variants detected in two Brazilian cities.•Comparison of Sanger sequencing and Next Generation Sequencing.</description><identifier>ISSN: 0888-7543</identifier><identifier>EISSN: 1089-8646</identifier><identifier>DOI: 10.1016/j.ygeno.2021.10.015</identifier><identifier>PMID: 34718131</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Brazil - epidemiology ; China ; Cities ; COVID-19 - epidemiology ; COVID-19 - virology ; genetic variants ; Genetic Variation ; High-Throughput Nucleotide Sequencing - methods ; Humans ; Mutation ; Phylogeny ; Sanger sequencing ; Sars-Cov-2 ; SARS-CoV-2 - genetics ; Spike ; Spike Glycoprotein, Coronavirus - genetics</subject><ispartof>Genomics (San Diego, Calif.), 2021-11, Vol.113 (6), p.4109-4115</ispartof><rights>2021</rights><rights>Copyright © 2021. Published by Elsevier Inc.</rights><rights>2021 Published by Elsevier Inc. 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c459t-492a954a6d41eb19d96f228dd02d4fe94750d4aa7cafd529f873c8f2ce084b2c3</citedby><cites>FETCH-LOGICAL-c459t-492a954a6d41eb19d96f228dd02d4fe94750d4aa7cafd529f873c8f2ce084b2c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0888754321003785$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34718131$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dorlass, Erick Gustavo</creatorcontrib><creatorcontrib>Lourenço, Karine Lima</creatorcontrib><creatorcontrib>Magalhães, Rubens Daniel Miserani</creatorcontrib><creatorcontrib>Sato, Hugo</creatorcontrib><creatorcontrib>Fiorini, Alex</creatorcontrib><creatorcontrib>Peixoto, Renata</creatorcontrib><creatorcontrib>Coelho, Helena Perez</creatorcontrib><creatorcontrib>Telezynski, Bruna Larotonda</creatorcontrib><creatorcontrib>Scagion, Guilherme Pereira</creatorcontrib><creatorcontrib>Ometto, Tatiana</creatorcontrib><creatorcontrib>Thomazelli, Luciano Matsumiya</creatorcontrib><creatorcontrib>Oliveira, Danielle Bruna Leal</creatorcontrib><creatorcontrib>Fernandes, Ana Paula</creatorcontrib><creatorcontrib>Durigon, Edison Luiz</creatorcontrib><creatorcontrib>Fonseca, Flavio Guimarães</creatorcontrib><creatorcontrib>Teixeira, Santuza Maria Ribeiro</creatorcontrib><title>Survey of SARS-CoV-2 genetic diversity in two major Brazilian cities using a fast and affordable Sanger sequencing strategy</title><title>Genomics (San Diego, Calif.)</title><addtitle>Genomics</addtitle><description>Genetic variants of SARS-CoV-2 have been emerging and circulating in many places across the world. Rapid detection of these variants is essential since their dissemination can impact transmission rates, diagnostic procedures, disease severity, response to vaccines or patient management. Sanger sequencing has been used as the preferred approach for variant detection among circulating human immunodeficiency and measles virus genotypes. Using primers to amplify a fragment of the SARS-CoV-2 genome encoding part of the Spike protein, we showed that Sanger sequencing allowed us to rapidly detect the introduction and spread of three distinct SARS-CoV-2 variants in two major Brazilian cities. In both cities, after the predominance of variants closely related to the virus first identified in China, the emergence of the P.2 variant was quickly followed by the detection of the P1 variant, which became dominant in less than one month after it was first detected. •Detection of genetic variants of SARS-CoV-2.•Sanger Sequencing of SARS-CoV-2 variants.•Three distinct SARS-CoV-2 variants detected in two Brazilian cities.•Comparison of Sanger sequencing and Next Generation Sequencing.</description><subject>Brazil - epidemiology</subject><subject>China</subject><subject>Cities</subject><subject>COVID-19 - epidemiology</subject><subject>COVID-19 - virology</subject><subject>genetic variants</subject><subject>Genetic Variation</subject><subject>High-Throughput Nucleotide Sequencing - methods</subject><subject>Humans</subject><subject>Mutation</subject><subject>Phylogeny</subject><subject>Sanger sequencing</subject><subject>Sars-Cov-2</subject><subject>SARS-CoV-2 - genetics</subject><subject>Spike</subject><subject>Spike Glycoprotein, Coronavirus - genetics</subject><issn>0888-7543</issn><issn>1089-8646</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU1vEzEQhi0EoqHwC5CQj1w2tb32xj6A1EZAkSohEeBqOfZ4cbSxi70btPDncUip4MJppJl33vl4EHpOyZIS2l3slnMPMS0ZYbRmloSKB2hBiVSN7Hj3EC2IlLJZCd6eoSel7AghqpXsMTpr-YpK2tIF-rmZ8gFmnDzeXH7cNOv0pWG4-sIYLHbhALmEccYh4vF7wnuzSxlfZfMjDMFEbMMYoOCphNhjg70pIzbRYeN9ys5sB8AbE3vIuMC3CaI96sqYzQj9_BQ98mYo8OwunqPPb998Wl83Nx_evV9f3jSWCzU2XDGjBDed4xS2VDnVecakc4Q57kHxlSCOG7OyxjvBlJer1krPLBDJt8y25-j1yfd22u7BWYh1gUHf5rA3edbJBP1vJYavuk8HLYVgHZPV4OWdQU71ijLqfSgWhsFESFPRTCjKqBRdV6XtSWpzKiWDvx9DiT5i0zv9G5s-YjsmK7ba9eLvDe97_nCqglcnAdQ_HQJkXWyo7wQXMthRuxT-O-AXKESs-A</recordid><startdate>20211101</startdate><enddate>20211101</enddate><creator>Dorlass, Erick Gustavo</creator><creator>Lourenço, Karine Lima</creator><creator>Magalhães, Rubens Daniel Miserani</creator><creator>Sato, Hugo</creator><creator>Fiorini, Alex</creator><creator>Peixoto, Renata</creator><creator>Coelho, Helena Perez</creator><creator>Telezynski, Bruna Larotonda</creator><creator>Scagion, Guilherme Pereira</creator><creator>Ometto, Tatiana</creator><creator>Thomazelli, Luciano Matsumiya</creator><creator>Oliveira, Danielle Bruna Leal</creator><creator>Fernandes, Ana Paula</creator><creator>Durigon, Edison Luiz</creator><creator>Fonseca, Flavio Guimarães</creator><creator>Teixeira, Santuza Maria Ribeiro</creator><general>Elsevier Inc</general><general>Published by Elsevier Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20211101</creationdate><title>Survey of SARS-CoV-2 genetic diversity in two major Brazilian cities using a fast and affordable Sanger sequencing strategy</title><author>Dorlass, Erick Gustavo ; Lourenço, Karine Lima ; Magalhães, Rubens Daniel Miserani ; Sato, Hugo ; Fiorini, Alex ; Peixoto, Renata ; Coelho, Helena Perez ; Telezynski, Bruna Larotonda ; Scagion, Guilherme Pereira ; Ometto, Tatiana ; Thomazelli, Luciano Matsumiya ; Oliveira, Danielle Bruna Leal ; Fernandes, Ana Paula ; Durigon, Edison Luiz ; Fonseca, Flavio Guimarães ; Teixeira, Santuza Maria Ribeiro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c459t-492a954a6d41eb19d96f228dd02d4fe94750d4aa7cafd529f873c8f2ce084b2c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Brazil - epidemiology</topic><topic>China</topic><topic>Cities</topic><topic>COVID-19 - epidemiology</topic><topic>COVID-19 - virology</topic><topic>genetic variants</topic><topic>Genetic Variation</topic><topic>High-Throughput Nucleotide Sequencing - methods</topic><topic>Humans</topic><topic>Mutation</topic><topic>Phylogeny</topic><topic>Sanger sequencing</topic><topic>Sars-Cov-2</topic><topic>SARS-CoV-2 - genetics</topic><topic>Spike</topic><topic>Spike Glycoprotein, Coronavirus - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dorlass, Erick Gustavo</creatorcontrib><creatorcontrib>Lourenço, Karine Lima</creatorcontrib><creatorcontrib>Magalhães, Rubens Daniel Miserani</creatorcontrib><creatorcontrib>Sato, Hugo</creatorcontrib><creatorcontrib>Fiorini, Alex</creatorcontrib><creatorcontrib>Peixoto, Renata</creatorcontrib><creatorcontrib>Coelho, Helena Perez</creatorcontrib><creatorcontrib>Telezynski, Bruna Larotonda</creatorcontrib><creatorcontrib>Scagion, Guilherme Pereira</creatorcontrib><creatorcontrib>Ometto, Tatiana</creatorcontrib><creatorcontrib>Thomazelli, Luciano Matsumiya</creatorcontrib><creatorcontrib>Oliveira, Danielle Bruna Leal</creatorcontrib><creatorcontrib>Fernandes, Ana Paula</creatorcontrib><creatorcontrib>Durigon, Edison Luiz</creatorcontrib><creatorcontrib>Fonseca, Flavio Guimarães</creatorcontrib><creatorcontrib>Teixeira, Santuza Maria Ribeiro</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Genomics (San Diego, Calif.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dorlass, Erick Gustavo</au><au>Lourenço, Karine Lima</au><au>Magalhães, Rubens Daniel Miserani</au><au>Sato, Hugo</au><au>Fiorini, Alex</au><au>Peixoto, Renata</au><au>Coelho, Helena Perez</au><au>Telezynski, Bruna Larotonda</au><au>Scagion, Guilherme Pereira</au><au>Ometto, Tatiana</au><au>Thomazelli, Luciano Matsumiya</au><au>Oliveira, Danielle Bruna Leal</au><au>Fernandes, Ana Paula</au><au>Durigon, Edison Luiz</au><au>Fonseca, Flavio Guimarães</au><au>Teixeira, Santuza Maria Ribeiro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Survey of SARS-CoV-2 genetic diversity in two major Brazilian cities using a fast and affordable Sanger sequencing strategy</atitle><jtitle>Genomics (San Diego, Calif.)</jtitle><addtitle>Genomics</addtitle><date>2021-11-01</date><risdate>2021</risdate><volume>113</volume><issue>6</issue><spage>4109</spage><epage>4115</epage><pages>4109-4115</pages><issn>0888-7543</issn><eissn>1089-8646</eissn><abstract>Genetic variants of SARS-CoV-2 have been emerging and circulating in many places across the world. Rapid detection of these variants is essential since their dissemination can impact transmission rates, diagnostic procedures, disease severity, response to vaccines or patient management. Sanger sequencing has been used as the preferred approach for variant detection among circulating human immunodeficiency and measles virus genotypes. Using primers to amplify a fragment of the SARS-CoV-2 genome encoding part of the Spike protein, we showed that Sanger sequencing allowed us to rapidly detect the introduction and spread of three distinct SARS-CoV-2 variants in two major Brazilian cities. In both cities, after the predominance of variants closely related to the virus first identified in China, the emergence of the P.2 variant was quickly followed by the detection of the P1 variant, which became dominant in less than one month after it was first detected. •Detection of genetic variants of SARS-CoV-2.•Sanger Sequencing of SARS-CoV-2 variants.•Three distinct SARS-CoV-2 variants detected in two Brazilian cities.•Comparison of Sanger sequencing and Next Generation Sequencing.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>34718131</pmid><doi>10.1016/j.ygeno.2021.10.015</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0888-7543
ispartof Genomics (San Diego, Calif.), 2021-11, Vol.113 (6), p.4109-4115
issn 0888-7543
1089-8646
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8552628
source MEDLINE; Elsevier ScienceDirect Journals; EZB-FREE-00999 freely available EZB journals
subjects Brazil - epidemiology
China
Cities
COVID-19 - epidemiology
COVID-19 - virology
genetic variants
Genetic Variation
High-Throughput Nucleotide Sequencing - methods
Humans
Mutation
Phylogeny
Sanger sequencing
Sars-Cov-2
SARS-CoV-2 - genetics
Spike
Spike Glycoprotein, Coronavirus - genetics
title Survey of SARS-CoV-2 genetic diversity in two major Brazilian cities using a fast and affordable Sanger sequencing strategy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T13%3A21%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Survey%20of%20SARS-CoV-2%20genetic%20diversity%20in%20two%20major%20Brazilian%20cities%20using%20a%20fast%20and%20affordable%20Sanger%20sequencing%20strategy&rft.jtitle=Genomics%20(San%20Diego,%20Calif.)&rft.au=Dorlass,%20Erick%20Gustavo&rft.date=2021-11-01&rft.volume=113&rft.issue=6&rft.spage=4109&rft.epage=4115&rft.pages=4109-4115&rft.issn=0888-7543&rft.eissn=1089-8646&rft_id=info:doi/10.1016/j.ygeno.2021.10.015&rft_dat=%3Cproquest_pubme%3E2591218566%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2591218566&rft_id=info:pmid/34718131&rft_els_id=S0888754321003785&rfr_iscdi=true